ADAPTIMMUNE THERAPEUTICS PLC's ticker is and the CUSIP is 00653A957. A total of 2 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $46,250 | +2212.5% | 50,000 | +2400.0% | 0.00% | – |
| Q3 2022 | $2,000 | -33.3% | 2,000 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | -83.3% | 2,000 | -77.0% | 0.00% | – |
| Q1 2022 | $18,000 | -84.7% | 8,700 | -72.4% | 0.00% | – |
| Q4 2021 | $118,000 | -63.7% | 31,500 | -49.9% | 0.00% | – |
| Q3 2021 | $325,000 | +400.0% | 62,900 | +311.1% | 0.00% | – |
| Q2 2021 | $65,000 | +116.7% | 15,300 | +168.4% | 0.00% | – |
| Q1 2021 | $30,000 | +15.4% | 5,700 | +72.7% | 0.00% | – |
| Q3 2020 | $26,000 | -96.9% | 3,300 | -96.1% | 0.00% | -100.0% |
| Q2 2020 | $844,000 | +7572.7% | 84,300 | +2061.5% | 0.00% | – |
| Q1 2020 | $11,000 | -66.7% | 3,900 | -49.4% | 0.00% | – |
| Q1 2019 | $33,000 | -74.8% | 7,700 | -66.2% | 0.00% | -100.0% |
| Q4 2018 | $131,000 | -42.8% | 22,800 | +34.9% | 0.00% | -50.0% |
| Q3 2018 | $229,000 | +854.2% | 16,900 | +745.0% | 0.00% | – |
| Q2 2018 | $24,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 91 | $49,000 | 0.00% |